Cargando…
Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years
INTRODUCTION: The effects of tafamidis on mortality in Val30Met and non-Val30Met patients with transthyretin amyloidosis with polyneuropathy (ATTR-PN) were evaluated. METHODS: The analyses were based on cumulative data from the Val30Met patients in the 18-month double-blind registration study and it...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229124/ https://www.ncbi.nlm.nih.gov/pubmed/32107748 http://dx.doi.org/10.1007/s40120-020-00180-w |